Main content

Andrew Dillon, National Institute for Health and Clinical Excellence
Stephen Sackur talks to Andrew Dillon of the National Institute for Health and Clinical Excellence, whose agency is responsible for deciding whether new drugs and treatments should be funded by the NHS.
Last on
Wed 31 Oct 2007
03:30GMT
More episodes
Broadcasts
- Tue 30 Oct 2007 04:30GMT
- Tue 30 Oct 2007 23:30GMT
- Wed 31 Oct 2007 03:30GMT